New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 13, 2014
09:34 EDTBCLIBrainStorm Cell raises $10.5M in a private placement
BrainStorm announced that it has entered into definitive agreements with a group of investors, including several healthcare-focused funds, in connection with a private placement of common stock and warrants to purchase common stock. Upon the closing of this financing, BrainStorm will receive gross proceeds of $10.5M, resulting from the issuance and sale of 42M shares of common stock at a price per share of 25c. Maxim Group LLC acted as sole placement agent for the financing.
News For BCLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 15, 2014
06:48 EDTBCLIBrainStorm receives $1.1M from Israel's OCS
BrainStorm Cell Therapeutics announced today that wholly-owned subsidiary Brainstorm Cell Therapeutics was awarded a grant of approximately $1.1M from Israel's Office of the Chief Scientist, or OCS. This is the eighth year that BrainStorm has been in receipt of grant support from the Office of the Chief Scientist, which is part of the Ministry of Trade and Industry Program to support innovative technologies in Israel. The funds will support the development NurOwn, BrainStorm's innovative mesenchymal stem cell-based platform for treating neurodegenerative diseases including BrainStorm's phase 2 clinical program in amyotrophic lateral sclerosis.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use